Home Healthcare Biotechnology ATP Assays Market

ATP Assays Market Size, Share & Trends Analysis Report By Type (Luminometric ATP Assays, Enzymatic ATP Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, Cell-based ATP Assays, Others), By Application (Clinical Diagnostics, Drug Discovery and Development, Others), By End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 17, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. ATP Assays Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Luminometric ATP Assays
    2. Enzymatic ATP Assays
    3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
    4. Cell-based ATP Assays
    5. Others
  2. ATP Assays Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Clinical Diagnostics
    2. Drug Discovery and Development
    3. Others
  3. ATP Assays Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical and Biotechnology Companies
    2. Clinical Diagnostics Laboratories
    3. Others
  4. Regional ATP Assays Market
    1. North America
      1. North America ATP Assays Market By Type 2022-2034 (USD MILLION/ Units)
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
      2. North America ATP Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Clinical Diagnostics
        2. Drug Discovery and Development
        3. Others
      3. North America ATP Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Clinical Diagnostics Laboratories
        3. Others
      4. U.S.
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      5. Canada
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
    2. Europe
      1. Europe ATP Assays Market By Type 2022-2034 (USD MILLION/ Units)
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
      2. Europe ATP Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Clinical Diagnostics
        2. Drug Discovery and Development
        3. Others
      3. Europe ATP Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Clinical Diagnostics Laboratories
        3. Others
      4. U.K.
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      5. Germany
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      6. France
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      7. Spain
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      8. Italy
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      9. Russia
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      10. Nordic
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      11. Benelux
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      12. Rest of Europe
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
    3. APAC
      1. APAC ATP Assays Market By Type 2022-2034 (USD MILLION/ Units)
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
      2. APAC ATP Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Clinical Diagnostics
        2. Drug Discovery and Development
        3. Others
      3. APAC ATP Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Clinical Diagnostics Laboratories
        3. Others
      4. China
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      5. Korea
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      6. Japan
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      7. India
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      8. Australia
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      9. Taiwan
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      10. South East Asia
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      11. Rest of Asia-Pacific
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
    4. Middle East and Africa
      1. Middle East and Africa ATP Assays Market By Type 2022-2034 (USD MILLION/ Units)
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
      2. Middle East and Africa ATP Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Clinical Diagnostics
        2. Drug Discovery and Development
        3. Others
      3. Middle East and Africa ATP Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Clinical Diagnostics Laboratories
        3. Others
      4. UAE
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      5. Turkey
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      6. Saudi Arabia
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      7. South Africa
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      8. Egypt
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      9. Nigeria
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      10. Rest of MEA
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
    5. LATAM
      1. LATAM ATP Assays Market By Type 2022-2034 (USD MILLION/ Units)
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
      2. LATAM ATP Assays Market By Application 2022-2034 (USD MILLION/ Units)
        1. Clinical Diagnostics
        2. Drug Discovery and Development
        3. Others
      3. LATAM ATP Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biotechnology Companies
        2. Clinical Diagnostics Laboratories
        3. Others
      4. Brazil
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      5. Mexico
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      6. Argentina
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      7. Chile
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      8. Colombia
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
      9. Rest of LATAM
        1. Luminometric ATP Assays
        2. Enzymatic ATP Assays
        3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
        4. Cell-based ATP Assays
        5. Others
        6. Clinical Diagnostics
        7. Drug Discovery and Development
        8. Others
        9. Pharmaceutical and Biotechnology Companies
        10. Clinical Diagnostics Laboratories
        11. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.